Patent · US Active

Dermatological, pharmaceutical composition suitable for oligonucleotides

US9249413B2 · kind B2 · utility

3Cited by

5References

17Claims

0Family size

Assignee

STERNA BIOLOGICALS GMBH & CO. KG · DE

Inventors

Thomas Schmidts · Gießen, DE
Holger Garn · Marburg, DE
Frank Runkel · Reiskirchen, DE

Key dates

Filing date	Feb 11, 2011
Grant date	Feb 2, 2016
Priority date	—
Expiry date	Jun 17, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/127
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a cosmetic and/or dermatological and/or pharmaceutical composition for the topical use and application of oligonucleotides, in particular antisense-oligonucleotides such as DNAzyme, siRNAs, asDNAs or ribozymes for use as an agent against inflammatory diseases by means of emulsions having a dispersed, internal, discontinuous aqueous phase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.